GR1008308B - Τοπικες φαρμακευτικες και ιατροτεχνολογικες συνθεσεις που περιεχουν συνδυασμους σουκραλφατης, υαλουρονικου οξεος, αργινινης και ενος φυσικου ενυδατικου παραγοντα - Google Patents
Τοπικες φαρμακευτικες και ιατροτεχνολογικες συνθεσεις που περιεχουν συνδυασμους σουκραλφατης, υαλουρονικου οξεος, αργινινης και ενος φυσικου ενυδατικου παραγονταInfo
- Publication number
- GR1008308B GR1008308B GR20130100323A GR20130100323A GR1008308B GR 1008308 B GR1008308 B GR 1008308B GR 20130100323 A GR20130100323 A GR 20130100323A GR 20130100323 A GR20130100323 A GR 20130100323A GR 1008308 B GR1008308 B GR 1008308B
- Authority
- GR
- Greece
- Prior art keywords
- sucralfat
- arginine
- hyaluronic acid
- medi
- tech
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title abstract 2
- 239000004475 Arginine Substances 0.000 title abstract 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 title abstract 2
- 229920002674 hyaluronan Polymers 0.000 title abstract 2
- 229960003160 hyaluronic acid Drugs 0.000 title abstract 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 title 1
- 235000012907 honey Nutrition 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 208000025157 Oral disease Diseases 0.000 abstract 1
- 230000004151 fermentation Effects 0.000 abstract 1
- 238000000855 fermentation Methods 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 208000030194 mouth disease Diseases 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000017520 skin disease Diseases 0.000 abstract 1
- 235000013618 yogurt Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/986—Milk; Derivatives thereof, e.g. butter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
- A61K8/988—Honey; Royal jelly, Propolis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Η παρούσα αίτηση αναφέρεται σε τοπικές συνθέσεις που περιλαμβάνουν, με βάση το συνολικό βάρος της σύνθεσης: 1. (Α) 0,05 - 5,0 τοις εκατό κ.β. σουκραλφάτη, 2. (Β) 0,05 - 5,0 τοις εκατό κ.β. υαλουρονικό οξύ ή υαλουρονικό άλας αυτού 3. (Γ) 0,05 - 5,0 τοις εκατό κ.β. ένα φυσικό ενυδατικό παράγοντα (π.χ. φυσικό γιαούρτι ή παράγωγα γιαουρτιού ή προϊόντων ζύμωσης γάλακτος ή μέλι ή προϊόντων μελιού ή μίγματα αυτών) 4. (Δ) 0,05 - 5,0 τοις εκατό κ.β. L- Αργινίνη, 5. (Ε) 80,0 - 98,0 τοις εκατό κ.β. νερό. Και 6. (ΣΤ) 1,0 - 15,0 τοις εκατό κ.β. από ένα φορέα ή όχημα, εκτός από το νερό. Οι εν λόγω συνθέσεις είναι σταθερές και παρουσιάζουν ρεολογικές ιδιότητες συγκρίσιμες με τις συνθέσεις που διατίθενται στην αγορά για παρόμοιες χρήσεις και εμφανίζουν μικρότερη διάρκεια θεραπείας ή και υψηλότερη εκκαθάριση των βλαβών του δέρματος και ως εκ τούτου, οι εν λόγω συνδυασμοί είναι χρήσιμοι στη θεραπεία των ασθενειών ή διαταραχών του δέρματος ή της στοματικής κοιλότητας.
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20130100323A GR1008308B (el) | 2013-05-31 | 2013-05-31 | Τοπικες φαρμακευτικες και ιατροτεχνολογικες συνθεσεις που περιεχουν συνδυασμους σουκραλφατης, υαλουρονικου οξεος, αργινινης και ενος φυσικου ενυδατικου παραγοντα |
| EP14386014.6A EP2810641B1 (en) | 2013-05-31 | 2014-05-30 | Topical pharmaceutical and medical device preparations containing combinations of sucralfate, hyaluronic acid, arginine and a natural moisturizing agent |
| HRP20200504TT HRP20200504T1 (hr) | 2013-05-31 | 2020-03-27 | Lokalni preparati farmaceutskih i medicinskih proizvoda koji sadrže kombinacije sukralfata, hijaluronske kiseline, arginina i prirodnog hidratantnog sredstva |
| CY20201100308T CY1122961T1 (el) | 2013-05-31 | 2020-03-31 | Τοπικα φαρμακευτικα και ιατροτεχνολογικα παρασκευασματα που περιεχουν συνδυασμους σουκραλφατης, υαλουρονικου οξεος, αργινινης και ενος φυσικου υγραντικου παραγοντα |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GR20130100323A GR1008308B (el) | 2013-05-31 | 2013-05-31 | Τοπικες φαρμακευτικες και ιατροτεχνολογικες συνθεσεις που περιεχουν συνδυασμους σουκραλφατης, υαλουρονικου οξεος, αργινινης και ενος φυσικου ενυδατικου παραγοντα |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR1008308B true GR1008308B (el) | 2014-10-02 |
Family
ID=51942536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR20130100323A GR1008308B (el) | 2013-05-31 | 2013-05-31 | Τοπικες φαρμακευτικες και ιατροτεχνολογικες συνθεσεις που περιεχουν συνδυασμους σουκραλφατης, υαλουρονικου οξεος, αργινινης και ενος φυσικου ενυδατικου παραγοντα |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP2810641B1 (el) |
| CY (1) | CY1122961T1 (el) |
| GR (1) | GR1008308B (el) |
| HR (1) | HRP20200504T1 (el) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3863608A1 (en) * | 2018-10-10 | 2021-08-18 | Hollister Incorporated | Stoma powder including skin health ingredients |
| KR20240015803A (ko) * | 2022-07-27 | 2024-02-06 | 주식회사 현대바이오랜드 | 수크랄페이트를 포함하는 피부 재생용 화장료 조성물 |
| GR1010853B (el) * | 2023-11-10 | 2025-01-10 | Ιουλια Τσετη | Συνθεση υαλουρονικου νατριου και σουκραλφατης καταλληλη για χορηγηση στη στοματικη κοιλοτητα |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US591688A (en) | 1897-10-12 | Bottle | ||
| JPS5978116A (ja) | 1982-10-27 | 1984-05-04 | Chugai Pharmaceut Co Ltd | スクラルフェ−ト製剤 |
| CA1218601A (en) | 1983-09-02 | 1987-03-03 | Angel B. Casillan | Sucralfate suspension |
| DE3430809A1 (de) | 1984-08-22 | 1986-03-06 | Merck Patent Gmbh, 6100 Darmstadt | Sucralfat-suspension |
| IT1203901B (it) | 1987-04-15 | 1989-02-23 | Lisapharma Spa | Composizioni farmaceutiche sotto forma di sospensioni stabili di sucralfato esenti da agenti sospendenti |
| GB8713747D0 (en) | 1987-06-12 | 1987-07-15 | Unilever Plc | Skin treatment composition |
| US5916880A (en) | 1987-12-21 | 1999-06-29 | Bukh Meditec A/S | Reduction of skin wrinkling using sulphated sugars |
| DK505588D0 (da) | 1988-02-26 | 1988-09-09 | Jesper Hamburger | Middel og anvendelse af samme |
| US5709873A (en) | 1988-02-26 | 1998-01-20 | Niels Bukh A/S | Method of treating conditions of teeth and their supporting tissue |
| US4918175A (en) | 1988-06-21 | 1990-04-17 | Marion Laboratories, Inc. | Bismuth (phosph/sulf)ated saccharides |
| US4975281A (en) | 1989-01-30 | 1990-12-04 | E. R. Squibb & Sons, Inc. | Anti-ulcer composition |
| US5618798A (en) | 1989-04-20 | 1997-04-08 | Bar-Shalom; Daniel | Use of sucralfate to treat baldness |
| CA1340994C (en) | 1989-09-21 | 2000-05-16 | Rudolf Edgar Dr. Falk | Treatment of conditions and disease |
| CA2020200A1 (en) * | 1990-06-29 | 1991-12-30 | Daniel Bar-Shalom | Use of sucralfate |
| US5639738A (en) | 1992-02-20 | 1997-06-17 | Hyal Pharmaceutical Corporation | Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs |
| US5792753A (en) | 1991-07-03 | 1998-08-11 | Hyal Pharmaceutical Corporation | Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs |
| US5425954A (en) | 1993-09-30 | 1995-06-20 | Curafas Incorporated | Topical amino acid - vitamin complex compositions for pharmaceutical and cosmetic use |
| AU5123396A (en) | 1995-04-03 | 1996-10-23 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical composition containing sucralfate |
| US6207713B1 (en) | 1997-09-17 | 2001-03-27 | Eric T. Fossel | Topical and oral delivery of arginine to cause beneficial effects |
| IT1301994B1 (it) * | 1998-08-05 | 2000-07-20 | Jasper Ltd Liability Co | Derivati dell'acido ialuronico. |
| ITMI20041550A1 (it) | 2004-07-29 | 2004-10-29 | Proge Farm Srl | Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide |
| ITMI20052035A1 (it) | 2005-10-26 | 2007-04-27 | Professional Dietetics Srl | Composizioni farmaceutiche cicatrizzanti sotto forma di crema a base di amminoacidi e sodio ialuronato |
| JP4800015B2 (ja) | 2005-11-22 | 2011-10-26 | 株式会社カロッツェリアジャパン | 皮膚炎発症抑制のための微生物培養物並びにそれらを用いた製品 |
| US7666859B2 (en) * | 2006-09-08 | 2010-02-23 | Norman Turkowitz | Skin compositions containing hydrocortisone |
| CA2639525A1 (en) * | 2008-09-16 | 2010-03-16 | Fayek Todary Michael | Topical composition for the protection and/or treatment of radiation related skin damages |
| ITMI20110033A1 (it) | 2011-01-17 | 2012-07-18 | Biofarmitalia Spa | Composizione terapeutica mucoadesiva a base di acido ialuronico per la prevenzione e terapia di lesioni epiteliali, delle mucose del corpo umano |
| WO2012150269A1 (en) | 2011-05-03 | 2012-11-08 | Dupont Nutrition Biosciences Aps | Probiotic bacteria for the topical treatment of skin disorders |
-
2013
- 2013-05-31 GR GR20130100323A patent/GR1008308B/el active IP Right Grant
-
2014
- 2014-05-30 EP EP14386014.6A patent/EP2810641B1/en active Active
-
2020
- 2020-03-27 HR HRP20200504TT patent/HRP20200504T1/hr unknown
- 2020-03-31 CY CY20201100308T patent/CY1122961T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2810641B1 (en) | 2020-02-26 |
| CY1122961T1 (el) | 2021-10-29 |
| EP2810641A1 (en) | 2014-12-10 |
| HRP20200504T1 (hr) | 2020-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX344238B (es) | Compuestos de tetrazol y métodos para preparar y usar los mismos. | |
| EA201800199A1 (ru) | Применение akkermansia muciniphila для лечения метаболических расстройств, увеличения расхода энергии и снижения веса, композиции, лекарственное стедство | |
| AR076677A1 (es) | Bifidobacterium longum ncc2705 (cncm i-2618) y trastornos inmunes. | |
| MX2012013703A (es) | Derivados de acido c-3-betulinico modificados como inhibidores de la maduracion del virus de inmunodeficiencia humana (vih). | |
| HK1216015A1 (zh) | 含有鋅氨基酸/三甲基甘氨酸鹵化物的個人清潔組合物 | |
| AR081872A1 (es) | Liquidos nutricionales sustancialmente limpidos que comprenden hmb de calcio y proteinas solubles | |
| MX2012004869A (es) | Formulaciones espesantes estables. | |
| PH12013500223A1 (en) | Oral care product and methods of use and manufacture thereof | |
| BR112014027981A2 (pt) | compostos do tipo fumagilol e métodos de produção e utilização dos mesmos | |
| MY170630A (en) | Freeze-dried formulations of fgf-18 | |
| EA201490653A1 (ru) | Производные эстра-1,3,5(10),16-тетраен-3-карбоксамида, способ их получения, содержащие их фармацевтические препараты, а также их применение для получения лекарственных средств | |
| PH12013502215A1 (en) | Beautiful-skin-promoting agent and use thereof | |
| CY1124115T1 (el) | Η χρηση τριβενζοϊκου γλυκερυλιου που περιεχει συνθεση σε νευροεκφυλιστικες διαταραχες | |
| MX357554B (es) | Concentrado o extracto de brote de aloe vera que tiene efectos superiores de promoción de célula de la piel, antioxidantes y anti-alergia. | |
| NZ601043A (en) | Nutritive compositions and methods of using same | |
| MY171048A (en) | Pharmaceutical composition for preventing or treating amyloid beta peptide-associated diseases or conditions | |
| MX2015008068A (es) | Unidad solida con alto contenido en fexofenadina y su procedimiento de preparacion. | |
| EP2575456A4 (en) | COMPOSITIONS AND METHODS FOR TREATING PRESENTATIONS | |
| CY1122961T1 (el) | Τοπικα φαρμακευτικα και ιατροτεχνολογικα παρασκευασματα που περιεχουν συνδυασμους σουκραλφατης, υαλουρονικου οξεος, αργινινης και ενος φυσικου υγραντικου παραγοντα | |
| PH12014502407A1 (en) | New alfentanil composition for the treatment of acute pain | |
| WO2016195194A3 (ko) | 신규한 tlr2 길항제 | |
| IN2014DN09240A (el) | ||
| CA2834182C (en) | Honey composition with l-alanyl-l-glutamine | |
| IN2014MN01381A (el) | ||
| PL2146951T3 (pl) | Nowe ligandy agonistyczne receptorów RAR, zastosowanie w medycynie ludzi jak również w kosmetyce |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PG | Patent granted |
Effective date: 20141121 |